High Serum Levels of Soluble Interleukin-2 Receptor and Absence of Detectable Levels of Soluble CD30 Molecule: A Specific Diagnostic Combination for Hairy Cell Leukemia

References

• Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall G. L., Bakhshi A., Depper J. M., Leonard W. J., Jaffe E. S., Waldmann T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proceedings of the National Academy of Sciences of the United States of America 1983; 80: 4522–4526
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Chilosi M., Semenzato G., Caligaris-Cappio F., Fiore-Donati L., Perona G., Janossy G. Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease. British Journal of Cancer 1984; 50: 415–417
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Greene W. C., Sarin P. S., Saxinger C., Blayney D. W., Blattner W. A., Goldman C. K., Bongiovanni K., Sharrow S., Depper G. M., Leonard W., Uchiyama T., Gallo R. C. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sezary leukemia and their distinction using anti-Tac monoclonal antibody identifying the human receptor to T cell growth factor. Journal of Clinical Investigation 1984; 73: 1711–1718
   PubMed Web of Science ®Google Scholar
• Greene W. C., Leonard W. J., Depper J. M., Nelson D. L., Waldmann T. A. The human interleukin-2 receptor: normal and abnormal expression in T cell and in leukemias induced by the human T-lymphotropic retroviruses. Annals of Internal Medicine 1986; 105: 560–572
   PubMed Web of Science ®Google Scholar
• Stein H., Gerdes J., Falini B. Phenotypic and genotypic markers of malignant lymphomas: cellular origin of Hodgkin's and Sternberg-Reed cells and implications for the classification of T-cell and B-cell lymphomas. Pathology of Cell Receptors and Tumor Markers, G. Seifert, K. Hubner. Gustav Fisher-Verlag, Stuttgart 1987; 121
   Google Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. Journal of Immunology 1985; 135: 3172–3177
   PubMed Web of Science ®Google Scholar
• Chilosi M., Semenzato G., Cetto G. L., Ambrosetti A., Fiore-Donati L., Perona G., Berton G., Lestani M., Scarpa A., Agostini C., Trentin L., Zambello R., Masciarelli M., Dazzi F., Vinante F., Caligaris-Cappio F., Pizzolo G. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987; 70: 1530–1535
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Chilosi M., Semenzato G. The soluble interleukin-2 receptor in haematological disorders. British Journal of Haematology 1987; 67: 377–380
   PubMed Web of Science ®Google Scholar
• Semenzato G., Foa R., Agostini C., Zambello R., Trentin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G. High serum levels of soluble interleukin 2 receptor in patients with chronic lymphocytic leukemia. Blood 1987; 70: 396–400
   PubMed Web of Science ®Google Scholar
• Ambrosetti A., Semenzato G., Prior M., Chilosi M., Vinante F., Vincenzi C., Zanotti R., Trentin L., Portuese A., Menestrina F., Perona G., Agostini C., Todeschini G., Pizzolo G. Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk. British Journal of Haematology 1989; 73: 181–186
   PubMed Web of Science ®Google Scholar
• Chilosi M., Semenzato G., Vinante F., Menestrina F., Piazzola E., Focchiatti V., Sabbioni R., Zanotti R., Pizzolo G. Increased levels of soluble interleukin 2 receptor in non-Hodgkin's lymphomas. American Journal of Clinical Pathology 1989; 92: 186–191
   PubMed Web of Science ®Google Scholar
• Gause A., Roschansky V., Tschiersch A., Smith K., Hasenclever D., Schmits R., Diehl V., Pfreundschuh M. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Annals of Oncology 1991; 2(S2)43–47
   PubMedGoogle Scholar
• Pizzolo G., Stein H., Josimovic-Alasevic O., Vinante F., Zanotti R., Chilosi M., Feller A. C., Diamantstein T. Increased serum levels of soluble IL-2 receptor, CD30, and CD8 molecules, and gamma interferon in angioimmu-noblastic lymphadenopathy. Possible pathogenetic role of immunoactivation mechanisms. British Journal of Haematology 1990; 75: 485–488
   PubMed Web of Science ®Google Scholar
• Dallenbach F., Josimovic-Alasevic O., Durkop H., Schwarting R., Diamantstein T., Matsuoka M., Takatsuki Stein H. Soluble CD30 antigen in the sera of patients with adult T-cell lymphoma/leukaemia (ATL): a marker for disease activity. Leucocyte typing IV: white cell differentiation antigens, W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E.G. von dem Borne, Kr. Oxford University Press, Oxford, New York, Tokyo 1989
   Google Scholar
• Josimovic-Alasevic O., Durkop H., Schwarting R., Backe E., Stein H., Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1 positive tumor cells in vitro and in vivo. 1. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. European Journal of Immunology 1989; 19: 157–162
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Vinante F., Chilosi M., Dallenbach F., Josimovic-Alasevic O., Diamantstein T., Stein H. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. British Journal of Haematology 1990; 75: 282–284
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., Scwarting R., Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that the Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Pui C. H. Serum interleukin-2 receptor: clinical and biological implications. Leukemia 1989; 3: 323–32
   PubMed Web of Science ®Google Scholar
• Schwarting R., Gerdes J., Stein H. A new monoclonal antibody of the Ki-1 family for the detection of Hodgkin's disease in formaldehyde fixed tissue sections. Leukocyte Typing III: While Cell Differentiation Antigens, A. J. McMichael. University Press, Oxford 1987; 574
   Google Scholar